Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program

Shinichi Ozawa, Chiaki Nakaseko, Miki Nishimura, Atsuo Maruta, Ryuko Cho, Chikako Ohwada, Hisashi Sakamaki, Hiroshi Sao, Shin Ichiro Mori, Shinichiro Okamoto, Kouichi Miyamura, Shunichi Kato, Takakazu Kawase, Yasuo Morishima, Yoshihisa Kodera

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Chronic graft-versus-host disease (GVHD) remains the major cause of late morbidity and mortality after allogeneic stem cell transplantation. We retrospectively analysed 2937 patients who underwent bone marrow transplantation from an unrelated donor (UR-BMT) facilitated by the Japan Marrow Donor Program (JMDP) and survived beyond day 100 after transplantation. The cumulative incidence of chronic GVHD (limited + extensive) or extensive chronic GVHD at 5 years post-transplant was 45·8% and 28·2%, respectively. On multivariate analysis, seven variables predicting chronic GVHD were identified: recipient age over 20 years, donor age over 30 years, primary diagnosis of chronic myeloid leukaemia, human leucocyte antigen (HLA)-A or -B mismatch, total body irradiation-containing regimen, platelet count not having reached 50 × 109/l by day 100, and prior acute GVHD. Among 2609 patients with haematological malignancy, overall survival was significantly higher in patients with limited chronic GVHD but lower in patients with extensive chronic GVHD compared with those without chronic GVHD. The cumulative incidence of relapse among patients with limited or extensive chronic GVHD was significantly lower than that among patients without chronic GVHD. Our results suggest that limited chronic GVHD provides a survival benefit to patients with haematological malignancies by reducing the risk of relapse without increasing the risk of death from chronic GVHD.

Original languageEnglish
Pages (from-to)142-151
Number of pages10
JournalBritish Journal of Haematology
Volume137
Issue number2
DOIs
Publication statusPublished - 2007 Apr

Fingerprint

Unrelated Donors
Homologous Transplantation
Graft vs Host Disease
Bone Marrow Transplantation
Japan
Bone Marrow
Tissue Donors
Recurrence
Incidence
Hematologic Neoplasms
Survival
Whole-Body Irradiation
Stem Cell Transplantation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
HLA Antigens
Platelet Count
Multivariate Analysis
Transplantation

Keywords

  • Chronic graft-versus-host disease
  • Graft-versus-leukaemia effect
  • Japan Marrow Donor Program
  • Relapse
  • Unrelated bone marrow transplantation

ASJC Scopus subject areas

  • Hematology

Cite this

Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor : Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. / Ozawa, Shinichi; Nakaseko, Chiaki; Nishimura, Miki; Maruta, Atsuo; Cho, Ryuko; Ohwada, Chikako; Sakamaki, Hisashi; Sao, Hiroshi; Mori, Shin Ichiro; Okamoto, Shinichiro; Miyamura, Kouichi; Kato, Shunichi; Kawase, Takakazu; Morishima, Yasuo; Kodera, Yoshihisa.

In: British Journal of Haematology, Vol. 137, No. 2, 04.2007, p. 142-151.

Research output: Contribution to journalArticle

Ozawa, S, Nakaseko, C, Nishimura, M, Maruta, A, Cho, R, Ohwada, C, Sakamaki, H, Sao, H, Mori, SI, Okamoto, S, Miyamura, K, Kato, S, Kawase, T, Morishima, Y & Kodera, Y 2007, 'Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program', British Journal of Haematology, vol. 137, no. 2, pp. 142-151. https://doi.org/10.1111/j.1365-2141.2007.06543.x
Ozawa, Shinichi ; Nakaseko, Chiaki ; Nishimura, Miki ; Maruta, Atsuo ; Cho, Ryuko ; Ohwada, Chikako ; Sakamaki, Hisashi ; Sao, Hiroshi ; Mori, Shin Ichiro ; Okamoto, Shinichiro ; Miyamura, Kouichi ; Kato, Shunichi ; Kawase, Takakazu ; Morishima, Yasuo ; Kodera, Yoshihisa. / Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor : Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. In: British Journal of Haematology. 2007 ; Vol. 137, No. 2. pp. 142-151.
@article{cb95b87b376141d7bf7b46ab48c32b8a,
title = "Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program",
abstract = "Chronic graft-versus-host disease (GVHD) remains the major cause of late morbidity and mortality after allogeneic stem cell transplantation. We retrospectively analysed 2937 patients who underwent bone marrow transplantation from an unrelated donor (UR-BMT) facilitated by the Japan Marrow Donor Program (JMDP) and survived beyond day 100 after transplantation. The cumulative incidence of chronic GVHD (limited + extensive) or extensive chronic GVHD at 5 years post-transplant was 45·8{\%} and 28·2{\%}, respectively. On multivariate analysis, seven variables predicting chronic GVHD were identified: recipient age over 20 years, donor age over 30 years, primary diagnosis of chronic myeloid leukaemia, human leucocyte antigen (HLA)-A or -B mismatch, total body irradiation-containing regimen, platelet count not having reached 50 × 109/l by day 100, and prior acute GVHD. Among 2609 patients with haematological malignancy, overall survival was significantly higher in patients with limited chronic GVHD but lower in patients with extensive chronic GVHD compared with those without chronic GVHD. The cumulative incidence of relapse among patients with limited or extensive chronic GVHD was significantly lower than that among patients without chronic GVHD. Our results suggest that limited chronic GVHD provides a survival benefit to patients with haematological malignancies by reducing the risk of relapse without increasing the risk of death from chronic GVHD.",
keywords = "Chronic graft-versus-host disease, Graft-versus-leukaemia effect, Japan Marrow Donor Program, Relapse, Unrelated bone marrow transplantation",
author = "Shinichi Ozawa and Chiaki Nakaseko and Miki Nishimura and Atsuo Maruta and Ryuko Cho and Chikako Ohwada and Hisashi Sakamaki and Hiroshi Sao and Mori, {Shin Ichiro} and Shinichiro Okamoto and Kouichi Miyamura and Shunichi Kato and Takakazu Kawase and Yasuo Morishima and Yoshihisa Kodera",
year = "2007",
month = "4",
doi = "10.1111/j.1365-2141.2007.06543.x",
language = "English",
volume = "137",
pages = "142--151",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor

T2 - Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program

AU - Ozawa, Shinichi

AU - Nakaseko, Chiaki

AU - Nishimura, Miki

AU - Maruta, Atsuo

AU - Cho, Ryuko

AU - Ohwada, Chikako

AU - Sakamaki, Hisashi

AU - Sao, Hiroshi

AU - Mori, Shin Ichiro

AU - Okamoto, Shinichiro

AU - Miyamura, Kouichi

AU - Kato, Shunichi

AU - Kawase, Takakazu

AU - Morishima, Yasuo

AU - Kodera, Yoshihisa

PY - 2007/4

Y1 - 2007/4

N2 - Chronic graft-versus-host disease (GVHD) remains the major cause of late morbidity and mortality after allogeneic stem cell transplantation. We retrospectively analysed 2937 patients who underwent bone marrow transplantation from an unrelated donor (UR-BMT) facilitated by the Japan Marrow Donor Program (JMDP) and survived beyond day 100 after transplantation. The cumulative incidence of chronic GVHD (limited + extensive) or extensive chronic GVHD at 5 years post-transplant was 45·8% and 28·2%, respectively. On multivariate analysis, seven variables predicting chronic GVHD were identified: recipient age over 20 years, donor age over 30 years, primary diagnosis of chronic myeloid leukaemia, human leucocyte antigen (HLA)-A or -B mismatch, total body irradiation-containing regimen, platelet count not having reached 50 × 109/l by day 100, and prior acute GVHD. Among 2609 patients with haematological malignancy, overall survival was significantly higher in patients with limited chronic GVHD but lower in patients with extensive chronic GVHD compared with those without chronic GVHD. The cumulative incidence of relapse among patients with limited or extensive chronic GVHD was significantly lower than that among patients without chronic GVHD. Our results suggest that limited chronic GVHD provides a survival benefit to patients with haematological malignancies by reducing the risk of relapse without increasing the risk of death from chronic GVHD.

AB - Chronic graft-versus-host disease (GVHD) remains the major cause of late morbidity and mortality after allogeneic stem cell transplantation. We retrospectively analysed 2937 patients who underwent bone marrow transplantation from an unrelated donor (UR-BMT) facilitated by the Japan Marrow Donor Program (JMDP) and survived beyond day 100 after transplantation. The cumulative incidence of chronic GVHD (limited + extensive) or extensive chronic GVHD at 5 years post-transplant was 45·8% and 28·2%, respectively. On multivariate analysis, seven variables predicting chronic GVHD were identified: recipient age over 20 years, donor age over 30 years, primary diagnosis of chronic myeloid leukaemia, human leucocyte antigen (HLA)-A or -B mismatch, total body irradiation-containing regimen, platelet count not having reached 50 × 109/l by day 100, and prior acute GVHD. Among 2609 patients with haematological malignancy, overall survival was significantly higher in patients with limited chronic GVHD but lower in patients with extensive chronic GVHD compared with those without chronic GVHD. The cumulative incidence of relapse among patients with limited or extensive chronic GVHD was significantly lower than that among patients without chronic GVHD. Our results suggest that limited chronic GVHD provides a survival benefit to patients with haematological malignancies by reducing the risk of relapse without increasing the risk of death from chronic GVHD.

KW - Chronic graft-versus-host disease

KW - Graft-versus-leukaemia effect

KW - Japan Marrow Donor Program

KW - Relapse

KW - Unrelated bone marrow transplantation

UR - http://www.scopus.com/inward/record.url?scp=33947509068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947509068&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2007.06543.x

DO - 10.1111/j.1365-2141.2007.06543.x

M3 - Article

C2 - 17391494

AN - SCOPUS:33947509068

VL - 137

SP - 142

EP - 151

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -